speb/financial-data huggingface dataset:
ACX.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 243284000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 201000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -6338000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 105352000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 191051000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 4034000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 4719000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 121071000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -1195000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Deferred Tax: -1195000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Depreciation: 7382000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 10174000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 2826000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 10174000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 2826000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 37867000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.19
ACX.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 7248000.00
ACX.TO income_statement (quarterly, 2025-03-31) — EBIT: 8569000.00
ACX.TO income_statement (quarterly, 2025-03-31) — EBITDA: 18743000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 201000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 12949000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -7920000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -5052000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: -157000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: 157000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -250000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 19072000.00
ACX.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 16974000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Goodwill: 43405000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 118080000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 292925000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 30005000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 179000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 2516000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 2516000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Interest Paid Cff: -2199000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 45076000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 332999000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -10809000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 201000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 17805000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 89715000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 107520000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -1065000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 10915000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -6137000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Net Debt: 76766000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 284000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Net Income: 7248000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 7248000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 7248000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 7248000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 7248000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 7248000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 7248000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -188000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: -2516000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -1400000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -1065000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -2516000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 1816000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 12720000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 163170000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -23341000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -335000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 125204000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 12700000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 13126000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 12700000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 13126000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 19015000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 7479200.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 18685000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 127000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Operating Income: 8841000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 135357000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 33730000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 19072000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 1242000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 16433000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: -272000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 74675000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 2516000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Other Properties: 282010000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Other Receivables: 15512000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Payables: 116352000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 116352000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 6136000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 6053000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -188000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -23549000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 126890000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 98004000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 10174000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -1400000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -6338000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Research And Development: 1364000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 0.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 15891000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Salaries And Wages: 541000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 208000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 16974000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 33730000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Short Term Debt Payments: -335000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Special Income Charges: -22000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 672000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 243284000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 125204000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -40800.00
ACX.TO income_statement (quarterly, 2025-03-31) — Tax Provision: -1195000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.15
ACX.TO balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 2285000.00
ACX.TO cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: 55000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 485001000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 332999000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 112239000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 243284000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 126516000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 241717000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 293950000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 120646000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 8819000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: -272000.00
ACX.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -272000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 469000.00
ACX.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 69980000.00
ACX.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 24701000.00
ACX.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 112010000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 99797000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 85430000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -133470000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 17024000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 1246000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 33626000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Basic EPS: -0.30
ACX.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 12949000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 11267000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -7512000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 20065000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 195123000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 24048000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 24048000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: 0.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Cash Financial: 24048000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -1946000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -12588000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 26029000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 10183000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 11494000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 195123000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 234119000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 4173000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 87136000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 177425000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 3930000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 4587000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 104384000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 984000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Deferred Tax: 984000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 10178000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 2730000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 10178000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 2730000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 33626000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.30
ACX.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -9959000.00
ACX.TO income_statement (quarterly, 2025-06-30) — EBIT: -7431000.00
ACX.TO income_statement (quarterly, 2025-06-30) — EBITDA: 2747000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -395000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 24048000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -1947000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 18517000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: -178000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 178000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -6575000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 15027000.00
ACX.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 15905000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Goodwill: 41192000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 109635000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 289200000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 24874000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 1207000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 1544000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 1544000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Interest Paid Cff: -1239000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 45554000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 321671000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -12588000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 4173000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 16135000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 87552000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 103687000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -995000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 11267000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 4173000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Net Debt: 63504000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 6527000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Net Income: -9959000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -9959000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -9959000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -9959000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -9959000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -9959000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -9959000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -158000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: -1544000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -995000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -995000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -1544000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -3886000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -5191000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 155730000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -7239000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 124484000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 12700000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 13300000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 12700000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 13300000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 10351000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Normalized Income: -3495600.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 26029000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 6349000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Operating Income: 173000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 112010000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 33859000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 15027000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 1242000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 14937000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: -7604000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 68443000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 1544000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 4846000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 277933000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Other Receivables: 14721000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Payables: 99797000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 99797000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 5185000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Pretax Income: -8975000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 4846000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -158000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -7354000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 102638000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 79688000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 10178000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -995000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Research And Development: 1220000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 5932000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Salaries And Wages: 968000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 115000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 15905000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 33859000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Special Income Charges: -1029000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1097000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 234119000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 124484000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -1140600.00
ACX.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 984000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.15
ACX.TO balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 2487000.00
ACX.TO cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: -439000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 455490000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 321671000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 108274000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 234119000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 111837000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 221371000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 278065000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 116987000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -856000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: -7604000.00
ACX.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -7604000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 229000.00
ACX.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 73041000.00
ACX.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 18240000.00
ACX.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 118260000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 94127000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 92911000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -139402000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 17474000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 1404000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 33892000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Basic EPS: 0.45
ACX.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 24048000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 11497000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -6081000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 20197000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 193216000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 14138000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 14138000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: 0.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Cash Financial: 14138000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -11538000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -5844000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 6512000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -18620000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -10870000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 193216000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 249299000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -2433000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 86700000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 180634000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 4586000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Current Debt: 26852000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 32068000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 126195000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -2478000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Deferred Tax: -2478000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 10578000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 2717000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 10578000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 2717000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 37404000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.41
ACX.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 15154000.00
ACX.TO income_statement (quarterly, 2025-09-30) — EBIT: 14668000.00
ACX.TO income_statement (quarterly, 2025-09-30) — EBITDA: 25246000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 960000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 14138000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -11538000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 431000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: -132000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: 132000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 2577000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 16510000.00
ACX.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 14403000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Goodwill: 42031000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 109208000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 294964000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 31560000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 1361000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 1992000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 1992000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Interest Paid Cff: -1695000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Inventory: 50181000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 331405000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -5844000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 3017000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 15611000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 55254000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 70865000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 3017000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -10746000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -2433000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Net Debt: 67968000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -2511000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Net Income: 15154000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 15154000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 15154000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 15154000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 15154000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 15154000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 15154000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -67000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: -1992000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -7729000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -7729000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -1992000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 155562000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -5777000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 140091000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 12594000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 11639000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 12594000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 11639000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 23898000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 14008200.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 6512000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -2643000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Operating Income: 13320000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 118260000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 33696000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 26852000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 16510000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 1242000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Other Gand A: 13414000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: 1348000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 67177000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 1992000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Other Properties: 283467000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Other Receivables: 15021000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Payables: 94127000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 94127000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 5145000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Pretax Income: 12676000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 319000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 0.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -67000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -6014000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 111170000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 78839000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 10578000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -10746000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -2433000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Research And Development: 1120000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 21086000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Salaries And Wages: 989000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 237000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 14403000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 33696000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Special Income Charges: -1229000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 1120000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 249299000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 140091000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 202200.00
ACX.TO income_statement (quarterly, 2025-09-30) — Tax Provision: -2478000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.15
ACX.TO balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 3238000.00
ACX.TO cash_flow (quarterly, 2025-09-30) — Taxes Refund Paid: 5000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 457998000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 304553000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 102933000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 249299000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 104940000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 208699000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 277364000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 82504000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 12091000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: 1348000.00
ACX.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 1348000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 229000.00
ACX.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 54439000.00
ACX.TO income_statement (annual, 2025-12-31) — +Operating Expense: 80177000.00
ACX.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 16072000.00
ACX.TO income_statement (annual, 2025-12-31) — +Total Revenue: 474928000.00
ACX.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 109301000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 95711000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 95711000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 78408000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 78408000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -145376000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -145376000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 17811000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 17811000.00
ACX.TO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 6237000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 3408000.00
ACX.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 33785000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 33482000.00
ACX.TO income_statement (annual, 2025-12-31) — Basic EPS: 0.46
ACX.TO income_statement (quarterly, 2025-12-31) — Basic EPS: 0.09
ACX.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 12792000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 14138000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 11462000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 11462000.00
ACX.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -49859000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -12529000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 19949000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 19949000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 190255000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 190255000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 34650000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 34650000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 34650000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 34650000.00
ACX.TO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: 0.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
ACX.TO balance_sheet (annual, 2025-12-31) — Cash Financial: 34650000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Cash Financial: 34650000.00
ACX.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -22161000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -757000.00
ACX.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -47706000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -18465000.00
ACX.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 91679000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 40453000.00
ACX.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: 17942000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 27470000.00
ACX.TO cash_flow (annual, 2025-12-31) — Changes In Cash: 21812000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 21231000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Common Stock: 190255000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 190255000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 248773000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 248773000.00
ACX.TO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 2610000.00
ACX.TO cash_flow (annual, 2025-12-31) — Common Stock Payments: -10151000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -3463000.00
ACX.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 368015000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 88827000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Current Assets: 184250000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 184250000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 4447000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 4447000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Current Debt: 26697000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 26697000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 31746000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 31746000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 127457000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 127457000.00
ACX.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: -7637000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -4948000.00
ACX.TO cash_flow (annual, 2025-12-31) — Deferred Tax: -7637000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: -4948000.00
ACX.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 42691000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 11761000.00
ACX.TO income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 11033000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 2760000.00
ACX.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 42691000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 11761000.00
ACX.TO income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 11033000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 2760000.00
ACX.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 37339000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 37034000.00
ACX.TO income_statement (annual, 2025-12-31) — Diluted EPS: 0.42
ACX.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.08
ACX.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 15579000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 3136000.00
ACX.TO income_statement (annual, 2025-12-31) — EBIT: 16212000.00
ACX.TO income_statement (quarterly, 2025-12-31) — EBIT: 406000.00
ACX.TO income_statement (annual, 2025-12-31) — EBITDA: 58903000.00
ACX.TO income_statement (quarterly, 2025-12-31) — EBITDA: 12167000.00
ACX.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 46000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -719000.00
ACX.TO cash_flow (annual, 2025-12-31) — End Cash Position: 34650000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 34650000.00
ACX.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -22161000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -757000.00
ACX.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 41820000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 27924000.00
ACX.TO cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -525000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: -58000.00
ACX.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 525000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 58000.00
ACX.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -6303000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -2055000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 15472000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 15472000.00
ACX.TO income_statement (annual, 2025-12-31) — General And Administrative Expense: 59318000.00
ACX.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 12036000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Goodwill: 41382000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Goodwill: 41382000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 104175000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 104175000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 303539000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 303539000.00
ACX.TO income_statement (annual, 2025-12-31) — Gross Profit: 106913000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 20474000.00
ACX.TO income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 4746000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 1999000.00
ACX.TO income_statement (annual, 2025-12-31) — Interest Expense: 8270000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 2218000.00
ACX.TO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 8270000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 2218000.00
ACX.TO cash_flow (annual, 2025-12-31) — Interest Paid Cff: -6833000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: -1700000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Inventory: 47017000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 47017000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 336402000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 336402000.00
ACX.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -47706000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -18465000.00
ACX.TO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 2610000.00
ACX.TO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 13656000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 10974000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 15502000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 15502000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Long Term Debt: 60932000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 60932000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 76434000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 76434000.00
ACX.TO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 13656000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 10974000.00
ACX.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -19340000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -6534000.00
ACX.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -7541000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -853000.00
ACX.TO balance_sheet (annual, 2025-12-31) — Net Debt: 52979000.00
ACX.TO balance_sheet (quarterly, 2025-12-31) — Net Debt: 52979000.00
ACX.TO cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 6332000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 2032000.00
ACX.TO income_statement (annual, 2025-12-31) — Net Income: 15579000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Net Income: 3136000.00
ACX.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 15579000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 3136000.00
ACX.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 15579000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 3136000.00
ACX.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 15579000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 3136000.00
ACX.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 15579000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 3136000.00
ACX.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 15579000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 3136000.00
ACX.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 15579000.00
ACX.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 3136000.00
ACX.TO cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -477000.00
ACX.TO cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -64000.00